<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04721899</url>
  </required_header>
  <id_info>
    <org_study_id>UW19-134</org_study_id>
    <nct_id>NCT04721899</nct_id>
  </id_info>
  <brief_title>Vitamin D and Endometrial Receptivity in Infertile Women</brief_title>
  <official_title>Effect of Vitamin D on Vaginal / Endometrial Biomarkers and Endometrial Receptivity in Women With Fertility Problems</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>The University of Hong Kong</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>The University of Hong Kong</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This is a prospective study comparing vaginal and endometrial biomarkers and the trophoblast&#xD;
      spheroid attachment rate in women with fertility problems before and after taking Vitamin D&#xD;
      for 8 weeks.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The aim of this study is to assess the effect of vitamin D supplementation on vaginal /&#xD;
      endometrial biomarkers and endometrial receptivity in women with fertility problems.&#xD;
&#xD;
      Women will have vaginal swab and endometrial biopsy twice. The first endometrial biopsy is&#xD;
      performed using a Pipelle sampler 7 days after luteinizing hormone surge (LH+7) at baseline&#xD;
      and the attachment rate of the trophoblast spheroid onto the isolated endometrial epithelial&#xD;
      cells will be assessed to assess endometrial receptivity at baseline. Implantation biomarkers&#xD;
      will be checked.&#xD;
&#xD;
      They will take Vitamin D 50,000 IU once per week for 4 weeks, followed by 50,000 IU once&#xD;
      every 2 weeks for 4 weeks. After 8 weeks of Vitamin D, a second vaginal swab and endometrial&#xD;
      biopsy using a Pipelle sampler by standard technique will be collected from the patients 7&#xD;
      days after luteinizing hormone surge (LH+7) and the endometrial receptivity will be compared.&#xD;
&#xD;
      The laboratory staff will not know whether the patient is taking any vitamin D when&#xD;
      performing the trophoblast spheroid attachment assay/ biomarkers.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">January 15, 2021</start_date>
  <completion_date type="Anticipated">August 1, 2022</completion_date>
  <primary_completion_date type="Anticipated">February 1, 2022</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Only</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Change in endometrial receptivity</measure>
    <time_frame>8 weeks</time_frame>
    <description>Assessed by the attachment rate of trophoblast spheroid attachment assay onto the isolated endometrial epithelial cells</description>
  </primary_outcome>
  <number_of_groups>3</number_of_groups>
  <enrollment type="Anticipated">105</enrollment>
  <condition>Infertility</condition>
  <arm_group>
    <arm_group_label>Vitamin D- recurrent implantation failure (RIF)</arm_group_label>
    <description>All women will have endometrial biopsy twice- at baseline and after 8 weeks of taking vitamin D After 8 weeks of Vitamin D, a second endometrial biopsy using a Pipelle sampler will be collected from the patients 7 days after luteinizing hormone surge (LH+7) and the endometrial receptivity will be compared.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Vitamin D- recurrent pregnancy loss (RPL)</arm_group_label>
    <description>All women will have endometrial biopsy twice- at baseline and after 8 weeks of taking vitamin D After 8 weeks of Vitamin D, a second endometrial biopsy using a Pipelle sampler will be collected from the patients 7 days after luteinizing hormone surge (LH+7) and the endometrial receptivity will be compared.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Vitamin D- infertility</arm_group_label>
    <description>All women will have endometrial biopsy twice- at baseline and after 8 weeks of taking vitamin D After 8 weeks of Vitamin D, a second endometrial biopsy using a Pipelle sampler will be collected from the patients 7 days after luteinizing hormone surge (LH+7) and the endometrial receptivity will be compared.</description>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Vitamin D</intervention_name>
    <description>Vitamin D 50,000 IU once per week for 4 weeks, followed by 50,000 IU once every 2 weeks for 4 weeks</description>
    <arm_group_label>Vitamin D- infertility</arm_group_label>
    <arm_group_label>Vitamin D- recurrent implantation failure (RIF)</arm_group_label>
    <arm_group_label>Vitamin D- recurrent pregnancy loss (RPL)</arm_group_label>
  </intervention>
  <biospec_retention>Samples With DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      endometrial biopsy&#xD;
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        Patients will be recruited from the Centre of Assisted Reproduction and Embryology, the&#xD;
        University of Hong Kong at Queen Mary Hospital. Infertile women who are in the waiting list&#xD;
        for IVF or have failed one IVF cycle will be recruited.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Age of women &lt; 40years old&#xD;
&#xD;
          -  Normal uterine cavity as demonstrated by pelvic scanning with or without saline&#xD;
             infusion sonogram or hysteroscopy&#xD;
&#xD;
          -  Regular ovulatory cycles&#xD;
&#xD;
        They will be divided into three groups:&#xD;
&#xD;
          -  RIF patients (n=35)- those who have failed to get pregnant after replacing four or&#xD;
             more cleavage stage embryos or two or more blastocysts in two consecutive transfers.&#xD;
&#xD;
          -  RPL patients (n=35)- those who have failed in three pregnancies before 24 weeks of&#xD;
             gestation and includes embryonic and fetal losses.&#xD;
&#xD;
          -  'Infertile group'(n=35)- infertility except RIF and RPL, e.g. those seeking for&#xD;
             preimplantation genetic testing, male factor infertility, unexplained infertility.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  History of any medical condition or medications that may predispose to vitamin D&#xD;
             sensitivity, altered vitamin D metabolism and/ or hypercalcemia, including active&#xD;
             tuberculosis or current therapy for tuberculosis, sarcoidosis, history of renal/&#xD;
             ureteral stones, parathyroid disease, renal or liver failure or current use of&#xD;
             anti-convulsants&#xD;
&#xD;
          -  Taking vitamin D supplement&#xD;
&#xD;
          -  Endometrial polyp or fibroid distorting the uterine cavity&#xD;
&#xD;
          -  Presence of hydrosalpinx not corrected surgically&#xD;
&#xD;
          -  Refusal to join the study&#xD;
&#xD;
             â€¢ Discontinuation criteria-&#xD;
&#xD;
          -  If the woman becomes pregnant during the study&#xD;
&#xD;
          -  Pelvic inflammatory disease/ uterine perforation after endometrial biopsy&#xD;
&#xD;
          -  Vitamin D toxicity (hypercalcemia)&#xD;
&#xD;
          -  Withdrawal by patient&#xD;
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>40 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Jennifer KY Ko</last_name>
    <phone>22554647</phone>
    <email>jenko@hku.hk</email>
  </overall_contact>
  <location>
    <facility>
      <name>Queen Mary Hospital</name>
      <address>
        <city>Hong Kong</city>
        <zip>000000</zip>
        <country>Hong Kong</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jennifer KY Ko, MBBS, MRCOG</last_name>
      <phone>22554647</phone>
      <email>jenko@hku.hk</email>
    </contact>
  </location>
  <location_countries>
    <country>Hong Kong</country>
  </location_countries>
  <verification_date>January 2021</verification_date>
  <study_first_submitted>January 19, 2021</study_first_submitted>
  <study_first_submitted_qc>January 19, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">January 25, 2021</study_first_posted>
  <last_update_submitted>May 28, 2021</last_update_submitted>
  <last_update_submitted_qc>May 28, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">June 3, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>vitamin D</keyword>
  <keyword>endometrial receptivity</keyword>
  <keyword>infertility</keyword>
  <keyword>recurrent pregnancy loss</keyword>
  <keyword>recurrent implantation failure</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Infertility</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Vitamin D</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

